This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Aska Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Makoto Okada: Innovator in Medicinal Chemistry
Introduction
Makoto Okada is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrimidine derivatives. His research focuses on developing compounds that can serve as effective treatments for various diseases.
Latest Patents
Makoto Okada holds a patent for a pyrimidine derivative, which is a compound characterized by the formula (I) or a salt thereof. This compound exhibits mPGES-1 inhibitory activity, making it useful as an active ingredient in medications aimed at the prophylactic and therapeutic treatment of diseases such as inflammation, pain, and rheumatism. He has 1 patent to his name.
Career Highlights
Okada is associated with Aska Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical sciences. His work has contributed to the creation of innovative therapeutic solutions that address pressing health issues.
Collaborations
Throughout his career, Makoto Okada has collaborated with notable colleagues, including Takashi Nose and Satoshi Maeda. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of medicinal chemistry.
Conclusion
In summary, Makoto Okada is a distinguished inventor whose work in pyrimidine derivatives has the potential to impact the treatment of various diseases. His contributions to Aska Pharmaceutical Co., Ltd. and collaborations with esteemed colleagues highlight his commitment to advancing medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile